Rating History for Merrimack Pharmaceuticals (MACK) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for MACK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/25/2018 N/A Downgrade Underweight
(Neutral)		 6.00
(14.00)		 12.07
(15.13)		 25.35% Details